Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases

Hortobagyi, 1998, Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate, J Clin Oncol, 16, 2038, 10.1200/JCO.1998.16.6.2038

Conte, 1994, Delayed progression of bone metastases with pamidronate therapy in breast cancer patients, Ann Oncol, 5, S41

Rodan, 1996, Bisphosphonates, J Clin Invest, 97, 2692, 10.1172/JCI118722

Hughes, 1989, Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow, J Clin Invest, 83, 1930, 10.1172/JCI114100

Hughes, 1995, Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo, J Bone Miner Res, 10, 1478, 10.1002/jbmr.5650101008

Murakami, 1995, A possible mechanism of the specific action of bisphosphonates on osteoclasts, Bone, 17, 137, 10.1016/S8756-3282(95)00150-6

Sahni, 1993, Bisphosphonates act on rat bone resorption through the mediation of oteoblasts, J Clin Invest, 91, 2004, 10.1172/JCI116422

van Holten-Verzantvoort, 1993, Palliative pamidronate treatment in patients with bone metastases from breast cancer, J Clin Oncol, 11, 491, 10.1200/JCO.1993.11.3.491

Berensen, 1998, Long term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events, J Clin Oncol, 16, 593, 10.1200/JCO.1998.16.2.593

Hortobagyi, 1996, Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastasis, N Engl J Med, 335, 1785, 10.1056/NEJM199612123352401

Berensen, 1996, Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma, N Engl J Med, 334, 448

Theriualt, 1999, Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic lesions, J Clin Oncol, 17, 846, 10.1200/JCO.1999.17.3.846

Hillner, 2000, American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer, J Clin Oncol, 18, 1378, 10.1200/JCO.2000.18.6.1378

Berenson, 2002, American Society of Clinical Oncology clinical practice guidelines, J Clin Oncol, 20, 3719, 10.1200/JCO.2002.06.037

Coleman, 2000, Optimizing treatment of bone metastases by ArediaR and ZometaR, Breast Cancer, 7, 361, 10.1007/BF02966406

Mashiba, 2001, Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib, J Bone Miner Res, 5, 613

Brumsen, 1997, Long-term effects of bisphosphonates on the growing skeleton, Medicine, 76, 266, 10.1097/00005792-199707000-00005

Glorieux, 1998, Cyclic administration of pamidronate in children with severe osteogenesis imperfecta, N Engl J Med, 339, 947, 10.1056/NEJM199810013391402

Whyte, 2003, Bisphosphonate-induced osteopetrosis, N Engl J Med, 349, 457, 10.1056/NEJMoa023110

Goodship, 1994, Use of a bisphosphonate (pamidronate) to modulate fracture repair in ovine bone, Ann Oncol, 5, S53

Cao, 2002, Raloxifene, estrogen and alendronate affect the processes of fracture repair differently in ovariectomized rats, J Bone Miner Res, 17, 2237, 10.1359/jbmr.2002.17.12.2237

Li, 1999, Effect of bisphosphonate (incadronate) on fracture healing of long bones in rats, J Bone Miner Res, 14, 969, 10.1359/jbmr.1999.14.6.969

Thiebaud, 1997, An in vitro and in vivo study of cytokines in the acute-phase response associated with bisphosphonates, Calcif Tiss Int, 61, 386, 10.1007/s002239900353

Kapitola, 2000, Effect of growth hormone and pamidronate on bone blood flow, bone mineral and IGF-I levels in the rat, Physiol Res, 49, S101

Kapitola, 1998, Effect of pamidronate on bone blood flow in oophorectomized rats, Physiol Res, 47, 237

Fournier, 2002, Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats, Cancer Res, 62, 6538

Santini, 2002, Pamidronate induces modifications of circulating angiogenic factors in cancer patients, Clin Cancer Res, 8, 1080

Wood, 2002, Novel antiangiogenic effects of the bisphosphonate compound zolendronic acid, J Pharmacol Exp Ther, 302, 1055, 10.1124/jpet.102.035295

Powles, 2002, Randomized, placebo-controlled trial of clodronate in patients with primary operable breast cancer, J Clin Oncol, 20, 3219, 10.1200/JCO.2002.11.080

Narai, 2003, Effects of alendronate on the removal torque of implants in rats with induced osteoporosis, Int J Oral Maxillofac Implants, 18, 218

Starck, 1995, Failure of osseointegrated dental implants after diphosphonate therapy for osteoporosis, Int J Oral Maxillofac Implants, 10, 74

Diel, 1998, Reduction in new metastases in breast cancer with adjuvant clodronate treatment, N Engl J Med, 339, 357, 10.1056/NEJM199808063390601